Transplantation of Ex Vivo Amplified Mononuclear Cells From Peripheral Blood Improves Rat Pulmonary Hypertension via <scp>CD14</scp> ‐ and <scp>CD163</scp> ‐Positive <scp>M2</scp> Macrophages

These findings suggest that MNC-QQc, particularly through CD14- and CD163-positive M2 macrophages, could be a novel treatment for PAH.

Authors

Institutions

Publication Details

Journal
Respirology
Published
2026-02-04
DOI
https://doi.org/10.1002/resp.70206
Primary Topic
Pulmonary Hypertension Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Transplantation of Ex Vivo Amplified Mononuclear Cells From Peripheral Blood Improves Rat Pulmonary Hypertension via CD14 ‐ and CD163 ‐Positive M2 Macrophages

Tetsutaro Nagaoka, Goh Murayama, Takashi Yoshida, K. Takahashi et al.
Respirology
Pulmonary Hypertension Research and Treatments
article

Transplantation of Ex Vivo Amplified Mononuclear Cells From Peripheral Blood Improves Rat Pulmonary Hypertension via CD14 ‐ and CD163 ‐Positive M2 Macrophages

Tetsutaro Nagaoka, Goh Murayama, Takashi Yoshida, K. Takahashi, Rie Ito‐Hirano, Yujin Nishioka, Yoshifumi Suzuki, Yuriko Terayama, Takeo Tsutsumi, Yuichi Nagata, Sachiko Kuriyama, Rica Tanaka
article en

Abstract

These findings suggest that MNC-QQc, particularly through CD14- and CD163-positive M2 macrophages, could be a novel treatment for PAH.

Respirology
Juntendo University (JP)
Openalex Percentile: Top 66%
Pulmonary Hypertension Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.